Your browser is no longer supported. Please, upgrade your browser.
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E24.64 EPS (ttm)6.65 Insider Own0.08% Shs Outstand2.67B Perf Week3.92%
Market Cap428.20B Forward P/E15.73 EPS next Y10.42 Insider Trans0.00% Shs Float2.63B Perf Month0.04%
Income17.77B PEG2.77 EPS next Q2.36 Inst Own69.50% Short Float0.62% Perf Quarter-3.32%
Sales89.19B P/S4.80 EPS this Y-4.20% Inst Trans0.09% Short Ratio2.75 Perf Half Y-1.63%
Book/sh26.04 P/B6.29 EPS next Y7.83% ROA10.20% Target Price187.17 Perf Year13.55%
Cash/sh9.68 P/C16.92 EPS next 5Y8.89% ROE27.00% 52W Range133.65 - 179.92 Perf YTD4.12%
Dividend4.24 P/FCF36.30 EPS past 5Y-0.30% ROI14.60% 52W High-8.92% Beta0.72
Dividend %2.59% Quick Ratio1.10 Sales past 5Y3.30% Gross Margin67.10% 52W Low22.61% ATR2.44
Employees134500 Current Ratio1.40 Sales Q/Q27.10% Oper. Margin22.60% RSI (14)52.58 Volatility1.43% 1.42%
OptionableYes Debt/Eq0.48 EPS Q/Q72.70% Profit Margin19.90% Rel Volume1.69 Prev Close160.12
ShortableYes LT Debt/Eq0.44 EarningsOct 19 BMO Payout60.90% Avg Volume5.93M Price163.87
Recom2.10 SMA201.49% SMA50-2.55% SMA200-1.10% Volume10,032,190 Change2.34%
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $187
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-19-21 04:54PM  
04:28PM  
04:05PM  
03:35PM  
03:11PM  
03:10PM  
03:06PM  
02:35PM  
02:34PM  
02:11PM  
02:00PM  
12:31PM  
12:11PM  
12:10PM  
11:15AM  
11:13AM  
10:46AM  
10:25AM  
10:16AM  
10:08AM  
10:01AM  
09:53AM  
09:46AM  
09:35AM  
09:26AM  
09:08AM  
08:58AM  
08:56AM  
07:45AM  
07:45AM  
07:33AM  
07:14AM  
07:09AM  
07:00AM  
06:47AM  
06:36AM  
06:31AM  
06:25AM  
06:12AM  
05:52AM  
02:35AM  
Oct-18-21 07:30PM  
06:10PM  
04:48PM  
04:36PM  
12:36PM  
12:07PM  
11:43AM  
11:03AM  
11:01AM  
10:29AM  
10:23AM  
09:59AM  
09:57AM  
09:22AM  
09:03AM  
08:19AM  
06:33AM  
06:20AM  
06:05AM  
05:39AM  
04:44AM  
04:28AM  
Oct-17-21 02:31PM  
05:57AM  
Oct-16-21 02:30PM  
06:01AM  
05:51AM  
Oct-15-21 09:14PM  
08:00PM  
05:44PM  
05:41PM  
04:24PM  
04:11PM  
03:49PM  
03:23PM  
03:22PM  
02:51PM  
02:42PM  
02:14PM  
01:54PM  
01:42PM  
01:14PM  
12:39PM  
12:15PM  
12:04PM  
11:51AM  
11:02AM  
10:15AM  
09:01AM  
06:16AM  
06:05AM  
02:40AM  
Oct-14-21 10:38PM  
10:28PM  
07:20PM  
06:15PM  
05:55PM  
04:23PM  
04:14PM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM